Status:
RECRUITING
Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.
Lead Sponsor:
University of Cagliari
Conditions:
Endometriosis
Eligibility:
FEMALE
18-50 years
Brief Summary
The primary objective of our study is to determine the percentage of patients with endometriosis who are non-responsive to medical therapy after 12 months and to compare the clinical and ultrasound ch...
Detailed Description
This will be an observational study without the use of medication, multicentric, prospective. Patients aged between 18 and 50 years, with a clinical and ultrasound diagnosis of endometriosis painful ...
Eligibility Criteria
Inclusion
- Age between 18 and 50 years;
- Patients with painful symptoms related to endometriosis (dyspareunia, dyschezia, dysmenorrhea, chronic pelvic pain, dysuria, periovulatory pain, with at least one of these symptoms presenting a Numerical Pain Rating Scale intensity \> 5);
- Indication for the administration of oral hormonal medical therapy for endometriosis;
- Acquisition of informed consent.
Exclusion
- Patients with contraindications to oral hormonal therapy;
- Current or past pelvic infections;
- History of malignancy or current suspicion of malignant gynecological lesions;
- Previous pelvic surgery (hysterectomy, salpingectomy, ovarian cyst removal, myomectomy, surgery for endometriosis, intestinal resections);
- Positive history for other causes of chronic pelvic pain;
- Postmenopausal status.
Key Trial Info
Start Date :
February 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
247 Patients enrolled
Trial Details
Trial ID
NCT06510647
Start Date
February 26 2024
End Date
May 31 2026
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico "Duilio-Casula"
Monserrato, Cagliari, Italy, 09042